Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase
Alan F. List(TE Laboratories (Ireland)), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Shaker R. Dakhil(Cancer Center of Kansas), Marilyn L. Slovak(City Of Hope National Medical Center), David R. Head(University of Southern California), Kenneth J. Kopecky(City Of Hope National Medical Center), Dan Douer(Memorial Sloan Kettering Cancer Center), Cheryl L. Willman(Mayo Clinic)
Cited by 63
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k